Medline (MDLN) Shares Outstanding (2024 - 2026)

Medline (MDLN) has 3 years of Shares Outstanding data on file, last reported at $846.0 million in Q1 2026.

• Quarterly Shares Outstanding rose 3578.26% year-over-year to $846.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $846.0 million (up 3578.26% YoY) and the FY2025 annual result came in at $812.0 million, down 95.14% from the prior year.
• Shares Outstanding grew to $846.0 million in Q1 2026 per MDLN's latest filing, from $812.0 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $16.7 billion in Q1 2025 and bottomed at $468.0 million in Q1 2026.
• The 3-year median for Shares Outstanding is $766.5 million (2024), against an average of $4.7 billion.
• The widest annual swing landed in 2025, when Shares Outstanding slumped 95.14%; it then jumped 3578.26% in 2026.
• Tracing MDLN's Shares Outstanding over 3 years: stood at $16.7 billion in 2024, then tumbled by 95.14% to $812.0 million in 2025, then climbed by 4.19% to $846.0 million in 2026.
• Per Business Quant, the three latest MDLN Shares Outstanding figures stand at $846.0 million (Q1 2026), $812.0 million (Q4 2025), and $23.0 million (Q1 2025).

Peer Comparison